CELLAMARE, Saverio
 Distribuzione geografica
Continente #
NA - Nord America 9.781
EU - Europa 3.271
AS - Asia 3.102
SA - Sud America 688
AF - Africa 90
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.941
Nazione #
US - Stati Uniti d'America 9.685
SG - Singapore 1.210
DE - Germania 1.102
CN - Cina 942
BR - Brasile 600
SE - Svezia 539
RU - Federazione Russa 459
HK - Hong Kong 397
IT - Italia 263
GB - Regno Unito 250
UA - Ucraina 209
VN - Vietnam 208
FI - Finlandia 162
FR - Francia 80
IN - India 74
CA - Canada 46
BE - Belgio 45
BD - Bangladesh 35
CI - Costa d'Avorio 35
AR - Argentina 32
ID - Indonesia 32
ES - Italia 31
JP - Giappone 31
TR - Turchia 31
MX - Messico 29
IR - Iran 28
IE - Irlanda 26
IQ - Iraq 25
NL - Olanda 23
PL - Polonia 21
ZA - Sudafrica 20
CZ - Repubblica Ceca 15
EC - Ecuador 15
AT - Austria 13
CO - Colombia 13
PK - Pakistan 11
KR - Corea 9
LT - Lituania 9
MA - Marocco 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
CH - Svizzera 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
GE - Georgia 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
GT - Guatemala 4
OM - Oman 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
GD - Grenada 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
PT - Portogallo 2
RO - Romania 2
SR - Suriname 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AN - Antille olandesi 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
MW - Malawi 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 16.937
Città #
Dallas 1.782
Fairfield 954
Chandler 764
Ashburn 724
Woodbridge 717
Singapore 598
Jacksonville 489
Houston 426
Hong Kong 387
Seattle 385
Nyköping 379
Wilmington 337
Ann Arbor 331
Cambridge 326
Beijing 255
Nanjing 160
Roxbury 151
Lawrence 146
Bari 118
Boardman 112
New York 112
Des Moines 95
Brooklyn 80
Princeton 79
Dearborn 71
Los Angeles 71
Ho Chi Minh City 62
Dong Ket 59
Munich 53
Nanchang 47
Jiaxing 45
Santa Clara 45
Brussels 44
Inglewood 43
São Paulo 42
Helsinki 39
Shenyang 39
San Diego 38
Hanoi 36
Hebei 36
Abidjan 35
Moscow 33
North Bergen 33
Buffalo 30
London 30
Dublin 26
Milan 26
Guangzhou 25
Tokyo 25
Council Bluffs 21
Montreal 21
Paris 20
Rio de Janeiro 20
Tianjin 20
Changsha 19
Jakarta 19
Atlanta 18
Belo Horizonte 18
Chicago 18
San Mateo 18
Washington 18
Brasília 17
Marseille 17
Warsaw 17
Zhengzhou 17
Shanghai 16
Chennai 15
Frankfurt am Main 15
Johannesburg 15
Leawood 15
Ningbo 15
Ardabil 14
Denver 14
West Jordan 14
Jinan 13
Kansas City 13
Manchester 13
Nuremberg 13
Porto Alegre 13
Stockholm 13
Augusta 12
The Dalles 12
Columbus 11
Falkenstein 11
San Francisco 10
Toronto 10
Amsterdam 9
Boydton 9
Brno 9
Dhaka 9
Norwalk 9
Boston 8
Curitiba 8
Hefei 8
Redwood City 8
Romola 8
Tashkent 8
Vienna 8
Ankara 7
Belém 7
Totale 11.630
Nome #
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.057
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 1.053
Design, synthesis and biological evaluation of indane 2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as b-amyloid aggregation inhibitors 202
Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data 195
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 190
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile 183
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease 178
Mind the Gap ! A Journey towards Computational Toxicology 173
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Aβ40 aggregation in vitro 170
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 165
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors 165
Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties 164
Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity 162
Repositioning of dantrolene for Alzheimer’s disease: new and old biological activities towards AD-related targets. 161
Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma 159
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 159
Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways 153
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 152
Linear Solvation Energy Relationships in Reversed-Phase Liquid Chromatography. Examination of Deltabond C8 as Stationary Phase for Measuring Lipophilicity Parameters 150
Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 150
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 150
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 149
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4′-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase 146
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 146
3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance 143
Partitioning behaviour of piracetam-type cognition enhancers 142
X-Ray Crystal Structure, Partitioning Behavior and Molecular Modeling Study of Piracetam-type Nootropics: Insights into the Pharmacophore 142
Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.) 141
Design, synthesis, biological evaluation, NMR and DFT studies of structurally-simplified trimethoxy benzamides as P-glycoprotein selective inhibitors: the role of molecular flatness 141
A novel strategy for the treatment of Hodgkin lymphoma 140
LFER and CoMFA studies on optical resolution of a-alkyl-a-aryloxyacetic acid methyl esters on DACH-DNB chiral stationary phase 140
Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding 137
Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6′-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N- methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors 135
Molecular optimization of O-glycoside inhibitors of blood coagulation factors. 132
Benzenesulfonamides Inhibitors of Carbonic Anhydrase: Study of Their Hydrophobicity by RPLC. QSAR: Quantitative Structure Activity Relationships 131
Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes 131
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 131
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration 129
Microfluidic pervaporation of ethanol from radiopharmaceutical formulations 127
(EN) GALLOYL BENZAMIDE-BASED COMPOUNDS AS JNK MODULATORS (FR) COMPOSES A BASE DE GALLOYL BENZAMIDE UTILISES EN TANT QUE MODULATEURS DE JNK 126
Determination of Lipophilicity and Hydrogen-bond Donor Acidity of Bioactive Sulphonyl-containing Compounds by Reversed-phase HPLC and Centrifugal Partition Chromatography and their Application to Structure-activity Relations 125
Anticoagulant activity of new glycoconjugated inhibitors Of factor Xa and thrombin 125
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 124
Lipophilicity Measurements of Benzenesulfonamide Inhibitors of Carbonic Anhydrase by Reversed-phase HPLC 124
Annelated medium-sized azaheterocycles as attractive scaffolds for CNS targeted leads. 124
Pyrrolo(3,2-c)pyridine derivatives as inhibitors of platelet aggregation 122
AZEPINO [4,3-b]INDOLE DERIVATIVES AS SELECTIVE INHIBITORS OF HUMAN BUTYRYLCHOLINESTERASE WITH PROTECTIVE EFFECTS AGAINST NMDA-INDUCED NEUROTOXICITY 122
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase 121
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors 120
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 120
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 118
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9 118
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. 115
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 111
Inhibiting Aβ1-40 in vitro aggregation by glycine-based molecular tongs: rational design and mechanistic implications 110
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 110
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease 109
Benzenesulfonamide inhibitors of carbonic anhydrase: study of their hydrophobicity by RPLC. 109
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation 108
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 108
Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams 107
The effect of Thapsia essential oils on bile composition in rats 106
Design, synthesis and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors 106
Enantiomeric Resolution of Sulfoxides on a DACH-DNB Chiral Stationary Phase: a Quantitative Structure-Enantioselective Retention Relationship (QSERR) Study 106
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as b-amyloid aggregation inhibitors 105
Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded gucocorticoid after aerosolization in mice 105
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 104
Estimation of the Binding Free Energy by Linear Interaction Energy Models 103
Studio dell’Idrolisi Chimica e Plasmatica di Aril-nipecotati ad Attività Gaba-mimetica Attraverso Analisi Regressionale 102
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 102
Bicyclic dilactam peptides and N-substituted derivatives of cyclic aminoacids as new inhibitors of amyloidogenesis 101
Teicoplanin-based enantiomeric separations in CZE using a partial filling technique 100
New N-arylmethyl derivatives of some cyclic amino acids and new peptidomimetics: synthesis and inhibition activity of insulin amyloid formation 100
Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides 99
Synthesis and anticonvulsant activity of some 1,2,3,3a-tetrahydropyrrolo[2,1-b]-benzothiazol-, -thiazol- or -oxazol-1-ones in rodents. 97
Development and analytical characterization of vitamin(s)-loaded chitosan nanoparticles for potential food packaging applications 96
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein. 96
Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors 95
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 94
Solid Phase Synthesis of Safinamide and Analogues as Potent and Selective MAO-B Inhibitors 94
Isatin 3-arylhydrazones: from inhibitors of amyloidogenesis to multitarget agents with potential in Alzheimer’s disease. 93
Direct chromatographic resolution of carnitine and O-acylcarnitine enantiomers on a teicoplanin-bonded chiral stationary phase 92
Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships 92
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 92
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 91
Oxazolidinone Amide Antibiotics 91
Ionization behaviour and tautomerism-dependent lipophilicity of pyridine-2(1H)-one cardiotonic agents 90
Effect of Thapsia essential oils on bile composition in rats 89
Derivatives of annulated tetrahydroazocines and tetrahydroazonines as cholinesterase inhibitors 87
Inhibition of uptake of [3H] dopamine into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 86
Insight into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 85
New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia 85
Coumarin as a versatile scaffold to selectively target biologically relevant cytochrome P450 enzymes: aromatase, steroid 11β-hydroxylase and aldosterone synthase 83
Thermodynamic Parameters, X-ray Structure, and QSAR Studies of Condensed Diazines as MAO Inhibitors 83
L'ISRP nella determinazione diretta di aril nipecotati in siero. 82
Antiplatelet activity of nipecotic acid derivatives 82
Synthesis and Pharmacological Evaluation of Perhydropyrrolo[3,4-c]pyridine Derivatives 82
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of PD 81
Inhibition of α-Ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 81
Toxicity to P12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 81
Totale 13.989
Categoria #
all - tutte 61.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021943 0 0 0 0 0 61 136 96 124 228 153 145
2021/20221.146 58 154 24 50 35 65 61 44 72 114 191 278
2022/20231.976 307 202 121 172 312 210 21 234 308 22 40 27
2023/2024755 54 113 40 94 58 146 33 27 30 22 20 118
2024/20252.414 77 57 229 110 61 170 211 221 133 104 332 709
2025/20264.174 710 546 1.681 628 543 66 0 0 0 0 0 0
Totale 17.306